Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 5, 2008, Pages 1789-1795

  Samelson, Elizabeth J ^a,b   Broe, Kerry E ^a   Demissie, Serkalem ^d   Beck, Thomas J ^e   Karasik, David ^a,b   Kathiresan, Sekar ^c,f   Kiel, Douglas P ^a,b  

^a Hebrew Senior Life   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 43249107435     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2492     Document Type: Article

References (38)

1. DL Lacey E Timms HL Tan MJ Kelley CR Dunstan T Burgess R Elliott A Colombero G Elliott S Scully H Hsu J Sullivan N Hawkins E Davy C Capparelli A Eli YX Qian S Kaufman I Sarosi V Shalhoub G Senaldi J Guo J Delaney WJ Boyle Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
2. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy HQ Nguyen S Wooden L Bennett T Boone G Shimamoto M DeRose R Elliott A Colombero HL Tan G Trail J Sullivan E Davy E Bucay L Renshaw-Gegg TM Hughes D Hill W Pattison P Campbell WJ Boyle Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
3. N Bucay I Sarosi CR Dunstan S Morony J Tarpley C Capparelli S Scully HL Tan W Xu DL Lacey WJ Boyle WS Simonet Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260 1268
4. A Mizuno N Amizuka K Irie A Murakami N Fujise T Kanno Y Sato N Nakagawa H Yasuda S Mochizuki T Gomibuchi K Yano N Shima N Washida E Tsuda T Morinaga K Higashio H Ozawa Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem Biophys Res Commun 247 1998 610 615
5. YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony C Capparelli J Li R Elliott S McCabe T Wong G Campagnuolo E Moran ER Bogoch G Van LT Nguyen PS Ohashi DL Lacey E Fish WJ Boyle JM Penninger Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
6. TA Bateman CR Dunstan VL Ferguson DL Lacey RA Ayers SJ Simske Osteoprotegerin mitigates tail suspension-induced osteopenia Bone 26 2000 443 449
7. AB Ross TA Bateman PJ Kostenuik VL Ferguson DL Lacey CR Dunstan SJ Simske The effects of osteoprotegerin on the mechanical properties of rat bone J Mater Sci Mater Med 12 2001 583 588
8. PJ Kostenuik C Capparelli S Morony S Adamu G Shimamoto V Shen DL Lacey CR Dunstan OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats Endocrinology 142 2001 4295 4304
9. Y Ichinose H Tanaka M Inoue S Mochizuki E Tsuda Y Seino Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading Calcif Tissue Int 75 2004 338 343
10. MS Ominsky PJ Kostenuik P Cranmer SY Smith JE Atkinson The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys Osteoporos Int 18 2007 1073 1082
11. OS Indridason L Franzson G Sigurdsson Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover Osteoporos Int 16 2005 417 423
12. S Khosla HM Arrighi Melton LJ 3rd EJ Atkinson WM O'Fallon C Dunstan BL Riggs Correlates of osteoprotegerin levels in women and men Osteoporos Int 13 2002 394 399
13. P Szulc LC Hofbauer AE Heufelder S Roth PD Delmas Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status J Clin Endocrinol Metab 86 2001 3162 3165
14. WS Browner LY Lui SR Cummings Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women J Clin Endocrinol Metab 86 2001 631 637
15. A Rogers R Eastell Circulating osteoprotegerin and receptor activator for nuclear factor κB ligand: clinical utility in metabolic bone disease assessment J Clin Endocrinol Metab 90 2005 6323 6331
16. Melton LJ 3rd SE Gabriel CS Crowson AN Tosteson O Johnell JA Kanis Cost-equivalence of different osteoporotic fractures Osteoporos Int 14 2003 383 388
17. Office of the Surgeon General Bone health and osteoporosis: a report of the Surgeon General 2004 United States Department of Health and Human Services, Office of the Surgeon General Rockville, MD
18. O Johnell JA Kanis An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos Int 17 2006 1726 1733
19. M Feinleib WB Kannel RJ Garrison PM McNamara WP Castelli The Framingham Offspring Study. Design and preliminary data Prev Med 4 1975 518 525
20. WB Kannel M Feinleib PM McNamara RJ Garrison WP Castelli An investigation of coronary heart disease in families. The Framingham offspring study Am J Epidemiol 110 1979 281 290
21. TR Dawber GF Meadors FE Moore Epidemiological approaches to heart disease: the Framingham Study Am J Pub Health 41 1951 279 286
22. S Demissie J Dupuis LA Cupples TJ Beck DP Kiel D Karasik Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study Bone 40 2007 743 750
23. MT Hannan DT Felson B Dawson-Hughes KL Tucker LA Cupples PW Wilson DP Kiel Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study J Bone Miner Res 15 2000 710 720
24. RB Martin DB Burr Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry J Biomech 17 1984 195 201
25. TJ Beck CB Ruff KE Warden Scott WW Jr GU Rao Predicting femoral neck strength from bone mineral data. A structural approach Invest Radiol 25 1990 6 18
26. BC Khoo TJ Beck QH Qiao P Parakh L Semanick RL Prince KP Singer RI Price In vivo short-term precision of hip structure analysis variables in comparison with bone mineral density using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials Bone 37 2005 112 121
27. WP Kannel W R Garrison The Framingham Study, section 35. Survival following initial cardiovascular events 1998 National Institutes of Health Bethesda, MD
28. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
29. P Mezquita-Raya M de la Higuera DF Garcia G Alonso ME Ruiz-Requena J de Dios Luna F Escobar-Jimenez M Munoz-Torres The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women Osteoporos Int 16 2005 1368 1374
30. A Stern GA Laughlin J Bergstrom E Barrett-Connor The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor κB legend with bone mineral density in older adults: the Rancho Bernardo study Eur J Endocrinol 156 2007 555 562
31. A Rogers G Saleh RA Hannon D Greenfield R Eastell Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women J Clin Endocrinol Metab 87 2002 4470 4475
32. Y Duan TJ Beck XF Wang E Seeman Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging J Bone Miner Res 18 2003 1766 1774
33. KW Oh EJ Rhee WY Lee SW Kim ES Oh KH Baek MI Kang MG Choi HJ Yoo SW Park The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women Clin Endocrinol (Oxf) 61 2004 244 249
34. KO Han JT Choi HA Choi IG Moon CH Yim WK Park HK Yoon IK Han The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone Clin Endocrinol (Oxf) 62 2005 349 353
35. H Uemura T Yasui Y Umino H Niki M Takikawa S Saito H Furumoto M Irahara Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover Bone 33 2003 860 866
36. G Schett S Kiechl K Redlich F Oberhollenzer S Weger G Egger A Mayr J Jocher Q Xu P Pietschmann S Teitelbaum J Smolen J Willeit Soluble RANKL and risk of nontraumatic fracture JAMA 291 2004 1108 1113
37. LC Hofbauer M Schoppet Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases JAMA 292 2004 490 495
38. S Khosla Minireview: the OPG/RANKL/RANK system Endocrinology 142 2001 5050 5055